FDA inspection
Ipsen BioPharm Ltd: FDA inspection ending Jul 6, 2018
FDA inspection 1059005 · Voluntary Action Indicated (VAI) · Wrexham
Key facts
| Inspection ID | 1059005 |
|---|---|
| Firm | Ipsen BioPharm Ltd |
| FEI number | 1000346340 |
| Address | Unit 9, Ash Road North |
| City | Wrexham |
| Country | United Kingdom |
| Fiscal year | 2018 |
| Inspection end date | Jul 6, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data